Taiwan FDA registration 2bbd9eca0815cabd402d767f4e616ce6
"Zeiss" Asfinafil spherical hydrophilic posterior chamber intraocular lens
TW: “蔡司” 艾斯菲那非球面親水性後房人工水晶體
Taiwan·Risk Class 3·CARL ZEISS MEDITEC AG;; Carl Zeiss Meditec SAS·Registered Mar 22, 2023 – Mar 22, 2028ActiveRegistration details
- Analysis ID
- 2bbd9eca0815cabd402d767f4e616ce6
- Customs Code
- DHA05603633302
Company information
- Manufacturer
- CARL ZEISS MEDITEC AG;; Carl Zeiss Meditec SAS
- Manufacturer Country
- France;;Germany
- Authorized Representative
- Carl Zeiss Co., Ltd. Taipei Branch
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- M Ophthalmology
- Product Type (Level 2)
- M.3600 Artificial Crystal
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Mar 22, 2023
- Expiry Date
- Mar 22, 2028
About this record
Access comprehensive regulatory information for "Zeiss" Asfinafil spherical hydrophilic posterior chamber intraocular lens in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 2bbd9eca0815cabd402d767f4e616ce6 and manufactured by CARL ZEISS MEDITEC AG;; Carl Zeiss Meditec SAS. The authorized representative in Taiwan is Carl Zeiss Co., Ltd. Taipei Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices